ICD-10-CM Code Z92.29

Personal history of other drug therapy

Version 2020 Billable Code Unacceptable Principal Diagnosis POA Exempt

Valid for Submission

Z92.29 is a billable code used to specify a medical diagnosis of personal history of other drug therapy. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code Z92.29 might also be used to specify conditions or terms like anti-d immunoglobulin given, antidepressant drug treatment stopped, anti-hepatitis b immunoglobulin given, appropriate medication administered safely during the perioperative period, aspirin given, aspirin given after arrival in hospital, etc The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

The code Z92.29 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.

ICD-10:Z92.29
Short Description:Personal history of other drug therapy
Long Description:Personal history of other drug therapy

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code Z92.29 are found in the index:


Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

  • Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual’s health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Anti-D immunoglobulin given
  • Antidepressant drug treatment stopped
  • Anti-hepatitis B immunoglobulin given
  • Appropriate medication administered safely during the perioperative period
  • Aspirin given
  • Aspirin given after arrival in hospital
  • Aspirin given prior to arrival at hospital
  • B12 injections stopped
  • Digitalization done
  • Drug course completed
  • Drug treatment no longer needed
  • Drug treatment stopped at end of clinical trial
  • Gamma globulin given
  • H/O: anticoagulant therapy
  • H/O: anticonvulsant therapy
  • H/O: high risk medication
  • H/O: hormone replacement
  • H/O: insulin therapy
  • H/O: regular medication
  • Hepatitis A gamma globulin given
  • History of angiotensin converting enzyme inhibitor therapy
  • History of angiotensin II receptor antagonist therapy
  • History of antiplatelet agent therapy
  • History of antiretroviral therapy
  • History of antiretroviral therapy during labor and delivery
  • History of bacillus Calmette-Guerin vaccination
  • History of beta adrenergic receptor blocking agent therapy
  • History of drug therapy
  • History of fenfluramine therapy
  • History of influenza vaccination
  • History of measles, mumps and rubella vaccination
  • History of nitrate therapy
  • History of peripartum antiretroviral therapy
  • History of pneumococcal vaccination
  • History of statin therapy
  • History of therapy with ototoxic medication
  • History of torsades de pointe caused by drug
  • History of torsades type ventricular tachycardia due to prolonged QT interval
  • History of tuberculosis drug therapy
  • History of varicella vaccination
  • History of yellow fever vaccination
  • Home nebulizer used since last encounter
  • Hormonal replacement therapy stopped
  • Inappropriate medication stopped
  • Injectable neuroleptic given
  • Injectable phenothiazine stopped
  • Injection given
  • Insulin treatment stopped
  • Intramuscular vitamin K prophylaxis given in hospital
  • Lithium stopped
  • Medication administered after lab visit
  • Medication administered after percutaneous coronary intervention
  • Medication administered before lab visit
  • Medication administered during lab visit
  • Medication administered during percutaneous coronary intervention
  • Medication administered following procedure
  • Medication administered less than 72 hours before percutaneous coronary intervention
  • Medication administered prior to percutaneous coronary intervention
  • Medication administered prior to percutaneous coronary intervention
  • Medication discontinued
  • Medication stopped - contra-indication
  • Medication stopped - ineffective
  • Medication stopped - interaction
  • Medication stopped - side effect
  • Nebulizer treatment since last encounter
  • Oral vitamin K prophylaxis given by community midwife
  • Oral vitamin K prophylaxis given in hospital
  • Premedication prescribed
  • Red blood cells issued
  • Reducing dose prescribed
  • Thrombolytic agent administered between 3 and 6 hours before percutaneous coronary intervention
  • Thrombolytic agent administered between 6 hours and 7 days before percutaneous coronary intervention
  • Thrombolytic agent administered less than 3 hours before percutaneous coronary intervention
  • Thyroxine treatment stopped
  • Treatment completed
  • Treatment given
  • Trigeminal nerve injected
  • Tuberculosis treatment completed
  • Warfarin therapy stopped

Diagnostic Related Groups

The ICD-10 code Z92.29 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2019 through 09/30/2020.

  • 949 - AFTERCARE WITH CC/MCC
  • 950 - AFTERCARE WITHOUT CC/MCC

Present on Admission (POA)

Z92.29 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here .

CMS POA Indicator Options and Definitions
POA Indicator CodePOA Reason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert Z92.29 to ICD-9

Code Classification

  • Factors influencing health status and contact with health services (Z00–Z99)
    • Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
      • Personal history of medical treatment (Z92)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020